FORM 8.1(c) & (d)(i)
IRISH TAKEOVER PANEL
DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022
BY AN OFFEROR, OFFEREE OR PARTIES ACTING IN CONCERT WITH THEM IN RESPECT OF DEALINGS FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1. KEY INFORMATION
(a) Full name of discloser:
Eaton Vance Management
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Horizon Therapeutics plc
(d) Status of person making the disclosure:
Horizon Therapeutics plc
(e) Date dealing undertaken:
12 January 2023
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?
2. INTERESTS AND SHORT POSITIONS
If there are positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (Note 1)
Class of relevant security:
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 .
3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE (Note 3)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
(i) Offeree, offeror or person acting in concert (except for a principal trader in the same group as a financial or other professional adviser acting in relation to the offer for the offeree or the offeror)
Price per unit
(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a financial or other professional adviser acting in relation to the offer for the offeree or the offeror
(b) Cash-settled derivative transactions
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
(d) Other dealings (including transactions in respect of new securities)
Nature of dealing
Price per unit
Redemption of Horizon Therapeutics shares included in a basket of securities
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?
Date of disclosure:
18th January 2023
Scott R. Kudlacik
+00 1 617-672-6531
Public disclosures under Rule 8.1 of the Rules must be made to a Regulatory Information Service.